Identification of a Novel De Novo Heterozygous SEC61A1 Variant in a Patient With Severe Congenital Neutropenia
Molecular Genetics & Genomic Medicine · 2026-05 · 14 (5)
DOI: 10.1002/mgg3.70217 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 29.04.2026. Verfasst von Zixuan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Neutropenia, Congenital Bone Marrow Failure Syndromes. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Background
Severe congenital neutropenia (SCN) is a heterogeneous hematopoietic disorder characterized by impaired granulocyte maturation and increased susceptibility to infections. Over 25 genes have been linked to SCN, yet the molecular pathogenesis remains unknown in 30%–50% of cases. This study aimed to expand the understanding of SEC61A1 variant‐mediated diseases.
Methods
Clinical data were collected from the patient. Whole‐exome sequencing was performed, followed by Sanger sequencing for familial validation. Bioinformatics, conservation, and protein structural analyses were conducted to evaluate candidate variants.
Results
We report an 11‐year‐old boy with decreased neutrophils and lymphocytes, and elevated proportions of monocytes and eosinophils. Bone marrow showed granulocytic hyperplasia with maturation arrest and nuclear abnormalities. Flow cytometric analysis of bone marrow cells is indicative of aberrant myeloid antigen differentiation and impaired granulocytic maturation. A novel de novo pathogenic SEC61A1 variant (c.1135 T > C; p.Trp379Arg) was identified. Structural analysis suggested that this variant may disrupt protein conformational stability.
Conclusions
The SEC61A1 c.1135 T > C (p.Trp379Arg) variant is considered likely pathogenic. This is the second reported SEC61A1 variant associated with SCN11, expanding the genetic and phenotypic spectrum of SCN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Genetic Diseases Key Laboratory of Sichuan Province and the Center for Medical Genetics, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology, Chengdu, China.
- Research Unit for Blindness Prevention, Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.
Förderung
- Chinese Academy of Medical Sciences
Zitieren
APA
Wang, Z., Jing, H., Chen, Y., Zhong, L., & Yang, J. (2026). Identification of a Novel De Novo Heterozygous SEC61A1 Variant in a Patient With Severe Congenital Neutropenia. Molecular Genetics & Genomic Medicine, 14(5). https://doi.org/10.1002/mgg3.70217
Vancouver
Wang Z, Jing H, Chen Y, Zhong L, Yang J. Identification of a Novel De Novo Heterozygous SEC61A1 Variant in a Patient With Severe Congenital Neutropenia. Molecular Genetics & Genomic Medicine. 2026;14(5). doi:10.1002/mgg3.70217
BibTeX
@article{Wang2026,
author = {Wang, Zixuan and Jing, Hui and Chen, Yuhan and Zhong, Ling and Yang, Jiyun},
title = {Identification of a Novel De Novo Heterozygous SEC61A1 Variant in a Patient With Severe Congenital Neutropenia},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
volume = {14},
number = {5},
doi = {10.1002/mgg3.70217}
}
EUVIMED